Providing prediction and prognosis for lymph node positive, early stage
breast cancer

Christy A Russell, MD
Senior Director Medical Affairs
Genomic Health

 

Oncotype DX Recurrence Score Distribution in Breast Cancer Patients
with BRCAl/2 Mutations

Rinat Yerushalmi, MD
Head, Breast Cancer Group
Davidoff Center
Rabin Medical Center

 

Real-Life Analysis Evaluating 1000 N0/Nlmi Estrogen Receptor (ER)+ Breast Cancer Patients for Whom Treatment Decisions Incorporated the 21-Gene Recurrence Score (RS) Result: Clinical Outcomes with Median Follow Up of 9 Years

Salomon M. Stemmer, MD
Head, Research Unit, Institute of Oncology
Davidoff Center, Rabin Medical Center

 

Breast Cancer Expert Panel

Chairwomen: Noa Efrat (Ben-Baruch), MD
Head, Dept of Oncology
Kaplan Medical Center